Ingenuity Canonical Pathways | UPmiRs | DNmiRs | ||
---|---|---|---|---|
 | pvalue | Count | pvalue | Count |
Superpathway of Cholesterol Biosynthesis | 8.51E-06 | 5 | Â | Â |
Glycogen Biosynthesis II (from UDP-D-Glucose) | 1.10E-03 | 2 | Â | Â |
Pyrimidine Deoxyribonucleotides De Novo Biosynthesis I | 2.09E-02 | 2 | Â | Â |
Regulation of the Epithelial-Mesenchymal Transition Pathway | 4.57E-02 | 5 | 7.76E-02 | 6 |
Leukocyte Extravasation Signaling | 5.50E-02 | 5 | 4.17E-03 | 9 |
Integrin Signaling | 5.50E-02 | 5 | 7.59E-05 | 12 |
PDGF Signaling | 1.98E-01 | 2 | 2.51E-04 | 7 |
CXCR4 Signaling | 2.12E-01 | 3 | 3.02E-03 | 8 |
PAK Signaling | 2.29E-01 | 3 | 2.57E-03 | 6 |
p53 Signaling | 2.64E-01 | 3 | 4.27E-03 | 6 |
IGF-1 Signaling | 2.64E-01 | 3 | 2.19E-05 | 9 |
p70S6K Signaling | 3.54E-01 | 3 | 1.20E-02 | 6 |
RhoA Signaling | 3.54E-01 | 3 | 2.95E-03 | 7 |
Axonal Guidance Signaling | 4.68E-01 | 5 | 5.50E-04 | 17 |
Molecular Mechanisms of Cancer | 5.28E-01 | 4 | 2.14E-03 | 14 |
NRF2-mediated Oxidative Stress Response | 5.42E-01 | 2 | 1.86E-03 | 9 |
STAT3 Pathway | 5.42E-01 | 1 | 1.78E-04 | 7 |
TGF-P Signaling | 5.98E-01 | 1 | 7.08E-05 | 8 |
Glioma Signaling | 6.35E-01 | 1 | 8.32E-04 | 7 |
Actin Cytoskeleton Signaling | 6.76E-03 | 9 | ||
Hepatic Fibrosis/Hepatic Stellate Cell Activation | 2.82E-04 | 11 | ||
Protein Kinase A Signaling | 9.33E-04 | 15 | ||
ERK/MAPK Signaling | 8.91E-03 | 8 | ||
PTEN Signaling | 6.03E-04 | 8 | ||
NF-κB Signaling | 5.37E-03 | 8 | ||
Regulation of Actin-based Motility by Rho | 2.45E-03 | 6 | ||
Cell Cycle: G2/M DNA Damage Checkpoint Regulation | 8.13E-03 | 4 | ||
Total number of UPmiR-targets: 29 | ||||
Total number of DNmiR-targets: 76 |